| Literature DB >> 2942517 |
R B Weiss, W D James, W B Major, M B Porter, C J Allegra, G A Curt.
Abstract
We have observed three forms of skin toxicity induced by the new antifol trimetrexate in a Phase I trial. They are: radiation recall, cellulitis at the infusion site, and generalized skin eruptions with erythroderma. A total of 25 episodes of some form of skin reaction occurred in 31 patients. The generalized eruption began about four days after drug administration and cleared within a week. The mechanism of skin toxicity of trimetrexate and other antifols is unknown.Entities:
Mesh:
Substances:
Year: 1986 PMID: 2942517 DOI: 10.1007/bf00194596
Source DB: PubMed Journal: Invest New Drugs ISSN: 0167-6997 Impact factor: 3.850